Shifting the paradigm on tissue removal and postoperative complications in breast reduction: A systematic review and meta-analysis.
Abstract
[BACKGROUND] The amount of tissue resection, measured in weight per breast, in breast reduction surgery has been considered a potential risk factor for complications.
[OBJECTIVE] We aimed to evaluate the effect of removing >1000 g versus <1000 g of breast tissue in women with macromastia.
[METHODS] A systematic search was performed on Pubmed, Embase, and Cochrane in March 2024 for studies that compared resection weight >1000 g versus <1000 g in reduction mammoplasty. Pooled odds ratios were computed for binary endpoints. We used R Studio for statistical analysis.
[RESULTS] We included 8 studies, with 1760 breasts, among which 493 (28.1%) had resection of ≥1000 g per breast. Women who had >1000 g of tissue resected per breast had lower risk of developing hypertrophic scar (OR 0.07; 95% CI 0.02-0.25; p < 0.001) and surgical site infection (OR 0.17, 95% CI 0.07-0.42, p < 0.001) than those who had <1000 g of breast resection. No statistical difference was observed among the groups for the outcomes of delayed wound healing and dehiscence, hematoma, fat or areolar necrosis, overall complications rates, and seroma.
[CONCLUSION] Among women who underwent reduction mammoplasty, resection of >1000 g of tissue per breast was associated with lower risk of hypertrophic scar development and surgical site infection than resection of <1000 g.
[OBJECTIVE] We aimed to evaluate the effect of removing >1000 g versus <1000 g of breast tissue in women with macromastia.
[METHODS] A systematic search was performed on Pubmed, Embase, and Cochrane in March 2024 for studies that compared resection weight >1000 g versus <1000 g in reduction mammoplasty. Pooled odds ratios were computed for binary endpoints. We used R Studio for statistical analysis.
[RESULTS] We included 8 studies, with 1760 breasts, among which 493 (28.1%) had resection of ≥1000 g per breast. Women who had >1000 g of tissue resected per breast had lower risk of developing hypertrophic scar (OR 0.07; 95% CI 0.02-0.25; p < 0.001) and surgical site infection (OR 0.17, 95% CI 0.07-0.42, p < 0.001) than those who had <1000 g of breast resection. No statistical difference was observed among the groups for the outcomes of delayed wound healing and dehiscence, hematoma, fat or areolar necrosis, overall complications rates, and seroma.
[CONCLUSION] Among women who underwent reduction mammoplasty, resection of >1000 g of tissue per breast was associated with lower risk of hypertrophic scar development and surgical site infection than resection of <1000 g.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 해부 | breast
|
유방 | dict | 8 | |
| 시술 | breast reduction
|
유방성형술 | dict | 2 | |
| 시술 | reduction mammoplasty
|
유방성형술 | dict | 2 | |
| 합병증 | surgical site infection
|
감염 | dict | 2 | |
| 합병증 | hypertrophic scar
|
비후성흉터 | dict | 2 | |
| 해부 | tissue
|
scispacy | 1 | ||
| 해부 | fat
|
scispacy | 1 | ||
| 합병증 | wound
|
scispacy | 1 | ||
| 합병증 | scar
|
scispacy | 1 | ||
| 합병증 | hematoma
|
혈종 | dict | 1 | |
| 합병증 | seroma
|
장액종 | dict | 1 | |
| 합병증 | necrosis
|
괴사 | dict | 1 | |
| 합병증 | dehiscence
|
상처열개 | dict | 1 | |
| 약물 | [BACKGROUND]
|
scispacy | 1 | ||
| 약물 | [OBJECTIVE]
|
scispacy | 1 | ||
| 약물 | Embase
|
scispacy | 1 | ||
| 질환 | macromastia
|
C0020565
Hypertrophy of Breast
|
scispacy | 1 | |
| 질환 | 1760 breasts
|
scispacy | 1 | ||
| 질환 | infection
|
C0009450
Communicable Diseases
|
scispacy | 1 | |
| 질환 | breast tissue
|
scispacy | 1 | ||
| 질환 | breasts
|
scispacy | 1 | ||
| 기타 | women
|
scispacy | 1 | ||
| 기타 | areolar
|
scispacy | 1 |
MeSH Terms
Humans; Mammaplasty; Female; Breast; Hypertrophy; Postoperative Complications; Cicatrix, Hypertrophic; Risk Factors
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- The impact of three-dimensional simulation and virtual reality technologies on surgical decision-making and postoperative satisfaction in aesthetic surgery: a preliminary study.
- Cutaneous fistula of the breast: A complication of cosmetic autologous fat transfer.
- Epidermal inclusion cyst after breast reduction mammoplasty.
- Penetrating globe injury following periocular hyaluronic acid filler injection: A case report.
- Clinical outcomes of synthetic absorbable mesh use in breast surgery: First case series in reconstruction and aesthetic mastopexy.